Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma

Clin Exp Allergy. 2020 Jul;50(7):869-872. doi: 10.1111/cea.13680. Epub 2020 Jun 25.

Andrew Wardlaw¹, Peter H Howarth^{2

3

4}, Elliot Israel⁵, Camille Taillé⁶, Santiago Quirce⁷, Stephen Mallett⁸, Stewart Bates⁹, Frank C Albers¹⁰, Namhee Kwon⁴

¹ Institute for Lung Health, University of Leicester, Leicester, UK.
² Global Medical Franchise, GSK House, Brentford, UK.
³ Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton and NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.
⁴ Respiratory Medical Franchise, GSK, Brentford, UK.
⁵ Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
⁶ AP-HP, Hôpital Bichat, Service de Pneumologie et Centre de Référence des Maladies Pulmonaires Rares, Dépt Hospitalo-Universitaire FIRE, Université Paris Diderot, INSERM UMR, Paris, France.
⁷ Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), and CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.
⁸ Clinical Statistics, GSK, Uxbridge, UK.
⁹ Respiratory Discovery Medicine, GSK, Stevenage, UK.
¹⁰ Respiratory Medical Franchise, GSK, Research Triangle Park, NC, USA.

No abstract available

Publication types